Inflammatory Bowel Disease CD56+ NK Cells
About: Inflammatory Bowel Disease CD56+ NK Cells come from IRB-consented donors with IBD. Relevant for exploring NK cell involvement in mucosal immune surveillance and inflammation.
Inflammatory Bowel Disease CD56 NK Cells for Autoimmune and Immunopathology Research
Inflammatory Bowel Disease (IBD) CD56 NK Cells are cryopreserved from peripheral blood of IRB-consented adult donors diagnosed with Inflammatory Bowel Disease. These CD56+ CD3− natural killer (NK) cells reflect disease-associated immune alterations and offer a critical resource for studying immune surveillance, inflammation, and cytotoxicity in the context of IBD.
Product Features
- Research Use Only (RUO), CD56+ enriched NK cells
- Isolated from clinically diagnosed IBD donors
- High viability and enrichment
- Cryopreserved in CryoStor® CS10 media
- Processed within 24 hours of collection
- Ethically sourced with IRB approval and HIPAA compliance
De-identified Donor Data
- Confirmed diagnosis of Inflammatory Bowel Disease
- Demographics: age, sex assigned at birth, race/ethnicity
- Self-reported clinical history and medication use
Applications
- Investigation of NK cell phenotypes and function in IBD
- Cytotoxicity, immune exhaustion, and single-cell analysis
- Disease mechanism studies and biomarker identification
- Preclinical immunotherapy development
Compliance and Quality Assurance
- IRB-approved collection and 21 CFR Part 11-compliant e-consent
- Standardized processing and quality protocols
- HIPAA-compliant data handling
Ordering & Customization
Inflammatory Bowel Disease CD56+ NK Cells are offered in standard or custom aliquot sizes. For regulatory documentation or international support, contact learnmore@sanguinebio.com.
Protocols & Documentation
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Frequently Asked Questions
1 Answer
All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/
1 Answer
YES – Certificate of analysis is available upon request.
1 Answer
Lead times vary from ready to ship inventory to prospective studies.
1 Answer
International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.
1 Answer
We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/
1 Answer
You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/
1 Answer
NO – no minimum order requirements.
1 Answer
For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com
1 Answer
YES – All three cell types are available.
Ask a Question
Need a custom CD56+ NK Cells cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.